A polymorphism in CYP17 and endometrial cancer risk.

Haiman, C A; Hankinson, S E; Colditz, G A; Hunter, D J; De Vivo, I

Haiman, C A; Hankinson, S E; Colditz, G A; Hunter, D J; De Vivo, I.

Affiliation

Haiman CA; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.

Cancer Res ; 61(10): 3955-60, 2001 May 15.

Article in En | MEDLINE | ID: mdl-11358812

Subject(s)

Endometrial Neoplasms/enzymology; Endometrial Neoplasms/genetics; Polymorphism, Genetic; Steroid 17-alpha-Hydroxylase/genetics; Adult; Alleles; Case-Control Studies; Endometrial Neoplasms/blood; Female; Genomic Imprinting; Hormones/blood; Humans; Middle Aged; Postmenopause; Premenopause; Risk Factors; White People/genetics

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Steroid 17-alpha-Hydroxylase / Endometrial Neoplasms Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Cancer Res Year: 2001 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links